Filgrastim Biosimilars Global Market Report 2024

Global Filgrastim Biosimilars Market Report 2024

Filgrastim Biosimilars Global Market Report 2024 – By Type Of Manufacturing (In-House Manufacturing, Contract Manufacturing organization), By Application (Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

Name: Filgrastim Biosimilars Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Filgrastim Biosimilars Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 250 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Filgrastim Biosimilars Market Definition

Filgrastim biosimilars refer to a biosimilar that is intended to treat patients who suffer bone marrow damage from extremely high radiation doses in a manner similar to how it helps cancer patients by stimulating the formation of white blood cells, making patients less susceptible to infections.

The two main types of manufacturing for the filgrastim biosimilar market are in-house manufacturing and contract manufacturing organization. A contract manufacturing organization, also known as a contract development and manufacturing organization, is a corporation that provides entire services to other pharma firms on a contractual basis, from drug discovery to drug production. The different applications include oncology, chronic and autoimmune diseases, blood disorders, growth hormone deficiency, infectious diseases, and others, and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Filgrastim Biosimilars Market Segmentation

The filgrastim biosimilars market covered in this report is segmented –

1) By Type Of Manufacturing: In-House Manufacturing, Contract Manufacturing organization

2) By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Global Filgrastim Biosimilars Market Size 2023 to 2028: Graph

Filgrastim Biosimilars Market Size 2024 And Growth Rate

The filgrastim biosimilars market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to emerging markets growth, increase in patent expiration, government initiatives, increased healthcare expenditure, low cost of biosimilars, strong pipeline of drugs and increase in biopharmaceutical r&d expenditure.

Filgrastim Biosimilars Market Growth Forecast

The filgrastim biosimilars market size is expected to see rapid growth in the next few years. It will grow to $1.66 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to aging population, increase in healthcare access,. Major trends in the forecast period include investing extensively in r&d activities for the development of effective and innovative biosimilars, production of biosimilars for neutropenia treatment to improve revenues and increasing their focus on m&a growth strategies.

Book your 30 minutes free consultation with our research experts

Filgrastim Biosimilars Market Driver: Neutropenia Prevalence Drives Growth In The Filgrastim Biosimilar Market

The increasing prevalence of neutropenia is expected to propel the growth of the filgrastim biosimilar market going forward. Neutropenia refers to a condition where the body does not have enough neutrophils, which are an important type of white blood cell that fights infections. Filgrastim biosimilars work by stimulating the production of neutrophils in the bone marrow, which increases the neutrophil count and helps fight infections. For instance, in August 2022, according to the National Center for Biotechnology Information, a US-based database for biomedical literature, the prevalence of neutropenia was 0.38% among Mexican-Americans, 0.79% among whites, and 4.5% among black participants. Thus, the increasing prevalence of neutropenia is driving the growth of the filgrastim biosimilar market.

Filgrastim Biosimilars Market Driver: Government-Led Biosimilar Initiatives Fuel Growth In The Filgrastim Biosimilar Market

Government initiatives for the development of biosimilars are expected to drive the filgrastim biosimilar markets market over the coming years. Governments worldwide are focusing on the development of biosimilars due to their cost-effective nature. The US Food and Drug Administration (FDA) launched a Biosimilar Action Plan, to increase treatment options. The Australian government is committed to the Biosimilar Awareness Initiative, and they improved their commitment by supporting the Generic and Biosimilar Medicines Association through a grant of $5 million to accept increased general biosimilar education and activities that promote the suitable dispensing, prescription, and use of biosimilar medicines. Hence, the government's initiatives for the development of biosimilars aid in the increased production and awareness that, in turn, support the growth of the filgrastim biosimilar markets market.

Global Filgrastim Biosimilars Market Major Players

Major companies operating in the filgrastim biosimilars market report are Teva Pharmaceutical Industries Ltd, Novartis International AG, Biocon Limited, Intas Biopharmaceuticals, Dr. Reddy's Laboratories, Pfizer, Cadila Healthcare Ltd, Abbott Laboratories, Reliance Life Science Pvt. Ltd, Gennova Biopharmaceuticals (Emcure), Sandoz Pty Ltd, Apotex Pty Ltd, Mylan, Kyowa Kirin Co. Ltd, Lupin Limited, Biocon Biologics, Coherus Biosciences Inc., North China Pharmaceutical Corporation, Tonghua Dongbaoare, Beijing SL Pharmaceutical, Mochida Pharmaceutical, Fuji Pharma, Amgen (Europe) GmbH, Napp Pharmaceuticals, Adello Biologics, Apobiologix (Apotex), Hospira, Tanvex BioPharma, Eurofarma Laboratórios

Global Filgrastim Biosimilars Market Restraint: Challenges And Hurdles In The Filgrastim Biosimilar Market: Navigating Regulatory Complexities And Patent Disputes

Stringent regulations imposed on approvals of biosimilars are anticipated to hinder the growth of the filgrastim biosimilar market in the forecast period. The governments of different regions impose different rules regarding the production and use of biologics and biosimilars. Further, issues such as patent infringement or agreement issues restrict the manufacturers of biosimilars from commercializing the government-approved biosimilars. The US Food and Drug Administration require double regulatory approval for biosimilars, restricting the use of biosimilars as interchangeable drugs for biologics, whereas, in Europe, the European Medicines Agency (EMA) approves biosimilars as interchangeable products for biologics. Sandoz, for example, received FDA approval for its first biosimilar, ZarxioTM (filgrastim-and) of the original biologic Neupogen. The consent depended on a comprehensive package of analytical, nonclinical, and clinical information that verified that Zarxio is highly similar to the US-licensed reference product. To get this approval, Sandoz even had to fight a legal battle with Amgen, which claims that Sandoz has infringed on its manufacturing process. These kinds of hurdles can restrict the growth of the filgrastim biosimilar market.

Global Filgrastim Biosimilars Market Trend: Amneal Pharmaceuticals' Fylnetra Marks A New Era Of Accessible Healthcare With Recombinant Dna Technology

Major companies operating in the filgrastim biosimilar market are developing innovative products with advanced technologies such as recombinant DNA technology to produce biosimilars. Recombinant DNA technology is a process that involves the creation of hybrid or chimeric DNA by inserting a foreign sequence into the DNA of an organism. For instance, in May 2023, Amneal Pharmaceuticals, a US-based pharmaceutical company launched FYLNETRA (pegfilgrastim-pbbk), a biosimilar to Amgen’s NEULASTA, in the United States indicated for the treatment and prevention of febrile neutropenia. It promotes the expansion and specialization of neutrophils originating from dedicated precursor cells, triggers their maturation, and improves the viability and efficiency of fully developed neutrophils, leading to dosage-dependent rises in neutrophil counts. The launch of Fylnetra contributes to the next wave of affordable medicines and drives access across patients, providers, and payors.

Global Filgrastim Biosimilars Market Trend: Amneal Pharmaceuticals And Kashiv Biosciences Revolutionize Cancer Care With Releuko (Filgrastim-Ayow), A Breakthrough Biosimilar For Febrile Neutropenia

Major companies operating in the filgrastim biosimilar market are developing innovative products such as Releuko (filgrastim-ayow) to better serve patients. Releuko (filgrastim-ayow) is a biosimilar referencing Neupogen (filgrastim) and is indicated for the treatment and prevention of febrile neutropenia in patients with cancer undergoing chemotherapy. For instance, in November 2022, Amneal Pharmaceuticals, a US-based pharmaceutical company, and Kashiv Biosciences, a US-based biosciences company launched Releuko (filgrastim-ayow) in the US market. It is contraindicated in patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim products or peg filgrastim products. The approval of Releuko marks the first biosimilar for Amneal, with two more decisions expected by the end of the year.

Filgrastim Biosimilars Market Merger And Acquisition: Biocon Biologics' Transformative Acquisition Of Viatris Inc.

In March 2022, Biocon Biologics, an India-based fully integrated biopharmaceutical company, acquired Viatris Inc. for $3.3 billion. This acquisition would build a distinctive, fully integrated, global biosimilars enterprise. This strategic alliance combines the strengths and complementary skills of both parties, positioning Biocon Biologics for the next ten years of value generation for all of our stakeholders. Viatris Inc. is a US-based pharmaceutical company that has developed a biosimilar of peg filgrastim.

Regional Analysis For The Global Filgrastim Biosimilars Market

North America was the largest region in the filgrastim biosimilar markets market in 2023. The Middle East is expected to be the fastest growing region in the global filgrastim biosimilar markets market during the forecast period. The regions covered in the filgrastim biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the filgrastim biosimilars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The filgrastim biosimilar markets consist of sales of Zarxio, Nivestym, and Releuko. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The filgrastim biosimilar markets market research report is one of a series of new reports from The Business Research Company that provides filgrastim biosimilar markets market statistics, including filgrastim biosimilar markets industry global market size, regional shares, competitors with a filgrastim biosimilar markets market share, detailed filgrastim biosimilar markets market segments, market trends and opportunities, and any further data you may need to thrive in the filgrastim biosimilar markets industry. This filgrastim biosimilar markets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Filgrastim Biosimilars Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$1.1 billion
Revenue Forecast In 2033	$1.66 billion
Growth Rate	CAGR of 10.7% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type Of Manufacturing: In-House Manufacturing, Contract Manufacturing organization 2) By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Teva Pharmaceutical Industries Ltd; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories; Pfizer; Cadila Healthcare Ltd; Abbott Laboratories; Reliance Life Science Pvt. Ltd; Gennova Biopharmaceuticals (Emcure); Sandoz Pty Ltd; Apotex Pty Ltd; Mylan; Kyowa Kirin Co. Ltd; Lupin Limited; Biocon Biologics; Coherus Biosciences Inc.; North China Pharmaceutical Corporation; Tonghua Dongbaoare; Beijing SL Pharmaceutical; Mochida Pharmaceutical; Fuji Pharma; Amgen (Europe) GmbH; Napp Pharmaceuticals; Adello Biologics; Apobiologix (Apotex); Hospira; Tanvex BioPharma; Eurofarma Laboratórios
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Filgrastim Biosimilars Market Characteristics

3. Filgrastim Biosimilars Market Trends And Strategies

4. Filgrastim Biosimilars Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Filgrastim Biosimilars Market Size and Growth

5.1. Global Filgrastim Biosimilars Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Filgrastim Biosimilars Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Filgrastim Biosimilars Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Filgrastim Biosimilars Market Segmentation

6.1. Global Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

In-House Manufacturing

Contract Manufacturing Organization

6.2. Global Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oncology

Chronic And Autoimmune Diseases

Blood Disorders

Growth Hormone Deficiency

Infectious Diseases

Other Applications

6.3. Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

7. Filgrastim Biosimilars Market Regional And Country Analysis

7.1. Global Filgrastim Biosimilars Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Filgrastim Biosimilars Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Filgrastim Biosimilars Market

8.1. Asia-Pacific Filgrastim Biosimilars Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Filgrastim Biosimilars Market

9.1. China Filgrastim Biosimilars Market Overview

9.2. China Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Filgrastim Biosimilars Market

10.1. India Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Filgrastim Biosimilars Market

11.1. Japan Filgrastim Biosimilars Market Overview

11.2. Japan Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Filgrastim Biosimilars Market

12.1. Australia Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Filgrastim Biosimilars Market

13.1. Indonesia Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Filgrastim Biosimilars Market

14.1. South Korea Filgrastim Biosimilars Market Overview

14.2. South Korea Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Filgrastim Biosimilars Market

15.1. Western Europe Filgrastim Biosimilars Market Overview

15.2. Western Europe Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Filgrastim Biosimilars Market

16.1. UK Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Filgrastim Biosimilars Market

17.1. Germany Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Filgrastim Biosimilars Market

18.1. France Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Filgrastim Biosimilars Market

19.1. Italy Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Filgrastim Biosimilars Market

20.1. Spain Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Filgrastim Biosimilars Market

21.1. Eastern Europe Filgrastim Biosimilars Market Overview

21.2. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Filgrastim Biosimilars Market

22.1. Russia Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Filgrastim Biosimilars Market

23.1. North America Filgrastim Biosimilars Market Overview

23.2. North America Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Filgrastim Biosimilars Market

24.1. USA Filgrastim Biosimilars Market Overview

24.2. USA Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Filgrastim Biosimilars Market

25.1. Canada Filgrastim Biosimilars Market Overview

25.2. Canada Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Filgrastim Biosimilars Market

26.1. South America Filgrastim Biosimilars Market Overview

26.2. South America Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Filgrastim Biosimilars Market

27.1. Brazil Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Filgrastim Biosimilars Market

28.1. Middle East Filgrastim Biosimilars Market Overview

28.2. Middle East Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Filgrastim Biosimilars Market

29.1. Africa Filgrastim Biosimilars Market Overview

29.2. Africa Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Filgrastim Biosimilars Market Competitive Landscape And Company Profiles

30.1. Filgrastim Biosimilars Market Competitive Landscape

30.2. Filgrastim Biosimilars Market Company Profiles

30.2.1. Teva Pharmaceutical Industries Ltd

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Novartis International AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Biocon Limited

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Intas Biopharmaceuticals

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Dr. Reddy's Laboratories

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Filgrastim Biosimilars Market Other Major And Innovative Companies

31.1. Pfizer

31.2. Cadila Healthcare Ltd

31.3. Abbott Laboratories

31.4. Reliance Life Science Pvt. Ltd

31.5. Gennova Biopharmaceuticals (Emcure)

31.6. Sandoz Pty Ltd

31.7. Apotex Pty Ltd

31.8. Mylan

31.9. Kyowa Kirin Co. Ltd

31.10. Lupin Limited

31.11. Biocon Biologics

31.12. Coherus Biosciences Inc.

31.13. North China Pharmaceutical Corporation

31.14. Tonghua Dongbaoare

31.15. Beijing SL Pharmaceutical

32. Global Filgrastim Biosimilars Market Competitive Benchmarking

33. Global Filgrastim Biosimilars Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Filgrastim Biosimilars Market

35. Filgrastim Biosimilars Market Future Outlook and Potential Analysis

35.1 Filgrastim Biosimilars Market In 2028 - Countries Offering Most New Opportunities

35.2 Filgrastim Biosimilars Market In 2028 - Segments Offering Most New Opportunities

35.3 Filgrastim Biosimilars Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Filgrastim Biosimilars Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Filgrastim Biosimilars Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Teva Pharmaceutical Industries Ltd Financial Performance

Table 75: Novartis International AG Financial Performance

Table 76: Biocon Limited Financial Performance

Table 77: Intas Biopharmaceuticals Financial Performance

Table 78: Dr. Reddy's Laboratories Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Filgrastim Biosimilars Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Filgrastim Biosimilars Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Filgrastim Biosimilars Market, Segmentation By Type Of Manufacturing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Teva Pharmaceutical Industries Ltd Financial Performance

Figure 75: Novartis International AG Financial Performance

Figure 76: Biocon Limited Financial Performance

Figure 77: Intas Biopharmaceuticals Financial Performance

Figure 78: Dr. Reddy's Laboratories Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Neutropenia Biologic Drug Treatment Global Market Report 2024 – By Drug Type (Filgrastim, Pegfilgrastim, Lenograstim, Lipegfilgrastim, Sargramostim), By Treatment Type (Antibiotic Drugs, Granulocyte-Colony-Stimulating Factor (G-CSF), Antifungal Drugs, Other Treatment Types), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Trastuzumab Biosimilars Global Market Report 2024 – By Product (Ogivri, Herzuma, Ontruzant, Trazimera, Other Products), By Indication (Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Other Indications), By Distribution Channel (Hospital Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Rituximab Biosimilars Global Market Report 2024 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Mail Order) – Market Size, Trends, And Global Forecast 2024-2033

View Report

G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2024 – By Type (Pegfilgrastim, Lenograstim, Filgrastim, Other Types), By Product (Tablet, Capsule, Other Products), By Application (Oncological Diseases, Blood Disorders, Chronic And Autoimmune Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pegfilgrastim Biosimilars Global Market Report 2024 – By Application (Chemotherapy Treatment, Transplantation, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Biosimilars Global Market Report 2024 – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others), By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Oral Biologics And Biosimilars Market - By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the filgrastim biosimilars market?

How will the filgrastim biosimilars market drivers and restraints affect the filgrastim biosimilars market dynamics? What forces will shape the filgrastim biosimilars industry going forward?

The filgrastim biosimilars market major growth driver - Neutropenia Prevalence Drives Growth In The Filgrastim Biosimilar Market. For further insights on the filgrastim biosimilars market, request a sample here

What is the forecast market size or the forecast market value of the filgrastim biosimilars market?

The filgrastim biosimilars market size has grown strongly in recent years. It will grow from $1.02 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to emerging markets growth, increase in patent expiration, government initiatives, increased healthcare expenditure, low cost of biosimilars, strong pipeline of drugs and increase in biopharmaceutical r&d expenditure. The filgrastim biosimilars market size is expected to see rapid growth in the next few years. It will grow to $1.66 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to aging population, increase in healthcare access,. Major trends in the forecast period include investing extensively in r&d activities for the development of effective and innovative biosimilars, production of biosimilars for neutropenia treatment to improve revenues and increasing their focus on m&a growth strategies. For further insights on the filgrastim biosimilars market, request a sample here

How is the filgrastim biosimilars market segmented?

The filgrastim biosimilars market is segmented
1) By Type Of Manufacturing: In-House Manufacturing, Contract Manufacturing organization
2) By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy For further insights on the filgrastim biosimilars market, request a sample here

Which region has the largest share of the filgrastim biosimilars market? What are the other regions covered in the report?

North America was the largest region in the filgrastim biosimilar markets market in 2023. The Middle East is expected to be the fastest growing region in the global filgrastim biosimilar markets market during the forecast period. The regions covered in the filgrastim biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the filgrastim biosimilars market, request a sample here.

Who are the major players in the filgrastim biosimilars market?

What are the key trends in the filgrastim biosimilars market?

Major trend in the filgrastim biosimilars market - Amneal Pharmaceuticals' Fylnetra Marks A New Era Of Accessible Healthcare With Recombinant Dna Technology. For further insights on the filgrastim biosimilars market, request a sample here.

What are the major opportunities in the filgrastim biosimilars market? What are the strategies for the filgrastim biosimilars market?

For detailed insights on the major opportunities and strategies in the filgrastim biosimilars market, request a sample here.

How does the filgrastim biosimilars market relate to the overall economy and other similar markets?

For detailed insights on filgrastim biosimilars market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the filgrastim biosimilars industry?

For detailed insights on the mergers and acquisitions in the filgrastim biosimilars industry, request a sample here.

What are the key dynamics influencing the filgrastim biosimilars market growth? SWOT analysis of the filgrastim biosimilars market.

For detailed insights on the key dynamics influencing the filgrastim biosimilars market growth and SWOT analysis of the filgrastim biosimilars industry, request a sample here.